Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bharat ParenteralsBOM:541096 -3.12%74 Days Payable is 101.04 as of Mar. 2026, which is 6% below its 10-year median of 107.08. GuruFocus rates BOM:541096 with a GF Score™ of 74/100 and a GF Value™ of ₹1,158.85 (Modestly Overvalued). The stock has 8 warning signs investors should review. Among 926 Drug Manufacturers companies, Bharat Parenterals ranks better than 68.14% on this metric.
The historical rank and industry rank for Bharat Parenterals's Days Payable or its related term are showing as below:
BOM:541096'
s Days Payable Range Over the Past 10 Years
Min: 66.98 Med: 107.08 Max: 163.92
Current: 128.19
During the past 13 years, Bharat Parenterals's highest Days Payable was 163.92. The lowest was 66.98. And the median was 107.08.
BOM:541096's Days Payable is ranked better than 68.14% of 926
companies
in the Drug Manufacturers industry
Industry Median: 90.22
vs BOM:541096: 128.19
Bharat Parenterals's Days Payable
declined
from Mar. 2025 (126.41) to Mar. 2026 (101.04).
It may suggest that Bharat Parenteralsaccelerated paying its suppliers.
The historical data trend for Bharat Parenterals's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Bharat Parenterals's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bharat Parenterals Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Bharat Parenterals's Days Payable distribution charts can be found below:
* The bar in red indicates where Bharat Parenterals's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Bharat Parenterals's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bharat Parenterals (BOM:541096) has a Days Payable of 101.04 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Bharat Parenterals and its competitors. This is near median its historical median of 107.08. Over the past decade, Bharat Parenterals' Days Payable has ranged from 66.98 to 163.92. According to the industry distribution chart, Bharat Parenterals ranks #295 out of 926 companies in the Drug Manufacturers industry, placing it in the top 31.9%.
Is Bharat Parenterals' Days Payable too high?
Bharat Parenterals' current Days Payable of 101.04 is near median its 10-year median of 107.08. Over the past 10 years, this metric has ranged from a low of 66.98 to a high of 163.92. The Drug Manufacturers industry median Days Payable is 90.22. Bharat Parenterals' value of 101.04 is 12% above this industry median. Based on the distribution chart, Bharat Parenterals ranks #295 out of 926 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Bharat Parenterals has a GF Score™ of 74/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bharat Parenterals' Days Payable compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Bharat Parenterals ranks #295 out of 926 companies for Days Payable. This puts Bharat Parenterals in the upper half of its industry. The industry median Days Payable is 90.22. Bharat Parenterals' value of 101.04 is 12% above this benchmark. Historically, Bharat Parenterals' own Days Payable has ranged from 66.98 to 163.92 over the past decade. While the company's 10-year median is 107.08 vs. the industry median of 90.22, Bharat Parenterals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.22, based on 926 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bharat Parenterals's current Days Payable of 101.04 is 12% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Bharat Parenterals and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bharat Parenterals's current Days Payable is 101.04, which is near median its own 10-year median of 107.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bharat Parenterals stock overvalued right now?
Based on GuruFocus' analysis, Bharat Parenterals (BOM:541096) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹1,158.85, compared to a current price of ₹1,375.00 — trading 18.7% above its estimated fair value. The current Days Payable is 101.04, which is near median its 10-year median of 107.08 and 12% above the Drug Manufacturers industry median of 90.22. Bharat Parenterals' overall GF Score™ is 74/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Bharat Parenterals (BOM:541096), the current Days Payable is 101.04 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bharat Parenterals (BOM:541096) Overvalued in 2026?
Based on GuruFocus' analysis, Bharat Parenterals stock appears to be overvalued.
The current stock price of ₹1,375.00 is trading 18.7% above its estimated GF Value™ of ₹1,158.85.
GuruFocus considers Bharat Parenterals to be Modestly Overvalued.
Key valuation signals for BOM:541096:
Days Payable: 101.04 (near median its 10-year median of 107.08)
GF Value™: ₹1,158.85 vs. price of ₹1,375.00 (18.7% above fair value)
Industry Position: 12% above the Drug Manufacturers median (#295 of 926)
No single metric tells the full story. See the BOM:541096 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bharat Parenterals Ltd is a pharmaceutical company. It provides various products such as Capsules, Dry Syrups, Sachets, Oral Liquids, Injections, Semisolids, and others. Geographically, the group has a business presence in India and Outside India.
74GF Score
Get the complete analysis for BOM:541096
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:541096 has been successfully added to your 
